Arie Belldegrun Insider Trading $KRON Kronos Bio, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Arie Belldegrun.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Arie Belldegrun. Arie Belldegrun is Director in Talon Therapeutics, Inc. ($EMLR) and Director in Arno Therapeutics, Inc ($ARNI) and Director in Cougar Biotechnology, Inc. ($CGRB) and Chairman, President and CEO in Kite Pharma, Inc. ($KITE) and Director in UroGen Pharma Ltd. ($URGN) and in Allogene Therapeutics, Inc. ($ALLO) and Director in Allogene Therapeutics, Inc. ($ALLO) and Director in Kronos Bio, Inc. ($KRON).

Arie Belldegrun in Kronos Bio, Inc.

Trading Symbol: KRON
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Arie Belldegrun: Director
Holdings: 438,703 shares
Latest Transaction: Jun 23 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Arie Belldegrun in Kronos Bio, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ALLO, ARNI, CGRB, KITE, KRON, EMLR, URGN

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 23 2021	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	A	24.18	20,600	498,108	20,600
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	1,304,563	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	650,000	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	228,315	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	173,333	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	1,304,563	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	16.15	253,251	4,090,004	2,315,314	2.1 M to 2.3 M (+12.28 %)
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	650,000	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	1,376,313	0	2,062,063	685.8 K to 2.1 M (+200.70 %)
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	228,315	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	685,750	0	685,750	0 to 685.8 K
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	173,333	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	240,872	0	679,575	438.7 K to 679.6 K (+54.91 %)
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	16.15	253,251	4,090,004	2,315,314	2.1 M to 2.3 M (+12.28 %)
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	182,866	0	438,703	255.8 K to 438.7 K (+71.48 %)
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	1,376,313	0	2,062,063	685.8 K to 2.1 M (+200.70 %)
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	685,750	0	685,750	0 to 685.8 K
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	240,872	0	679,575	438.7 K to 679.6 K (+54.91 %)
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	182,866	0	438,703	255.8 K to 438.7 K (+71.48 %)

Page: 1